Christensen Anne Friesgaard, Sorensen Grith Lykke, Junker Kirsten, Revald Peter, Varnum Claus, Issa Saida Farah, Junker Peter, Sorensen Flemming Brandt
Department of Internal Medicine, Lillebaelt Hospital, Vejle, Denmark.
Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
APMIS. 2019 Aug;127(8):588-593. doi: 10.1111/apm.12974.
Microfibrillar-associated protein 4 (MFAP4) is a non-structural matrix protein with cell regulatory activities and a potential as seromarker for fibrosis. We aimed to study the occurrence of MFAP4 in the synovial membrane from patients with rheumatoid arthritis (RA) vs osteoarthritis (OA). Formaldehyde-fixed synovial tissue sections, from patients with RA (N = 6) and OA (N = 6) undergoing total hip arthroplasty, were deparaffinized and immunostained with monoclonal antibodies against MFAP4. Elastin was detected using ElastiKit. MFAP4 in serum (sMFAP4) and synovial fluid was measured by an immunoassay. MFAP4 was present in synovial biopsies from both RA and OA patients, particularly prominent in deep arterioles where it colocalized with elastin. Notably however, MFAP4 was absent from the internal elastic lamina in RA arterioles irrespective of disease duration and synovitis activity, while present although with irregular staining patterns in OA specimens. sMFAP4 was increased in RA and OA serum vs healthy controls: median (interquartile range) 29.8 (25.3-39.1) and 25.5 U/L (18.1-43.3) vs 17.7 U/L (13.7-21.2), p = 0.006 and p = 0.02, respectively The concentration of synovial fluid was lower than in serum in both RA and OA. These findings may suggest that MFAP4 is involved in adaptive vessel wall remodeling associated with chronic joint disease.
微原纤维相关蛋白4(MFAP4)是一种具有细胞调节活性的非结构基质蛋白,有作为纤维化血清标志物的潜力。我们旨在研究类风湿关节炎(RA)患者与骨关节炎(OA)患者滑膜中MFAP4的出现情况。对接受全髋关节置换术的RA患者(N = 6)和OA患者(N = 6)的甲醛固定滑膜组织切片进行脱蜡处理,并用抗MFAP4单克隆抗体进行免疫染色。使用弹性蛋白试剂盒检测弹性蛋白。通过免疫测定法测量血清(sMFAP4)和滑液中的MFAP4。MFAP4存在于RA和OA患者的滑膜活检组织中,在深部小动脉中尤为突出,与弹性蛋白共定位。然而,值得注意的是,无论疾病持续时间和滑膜炎活动如何,RA小动脉的内弹性膜中均不存在MFAP4,而在OA标本中虽然存在但染色模式不规则。与健康对照相比,RA和OA血清中的sMFAP4升高:中位数(四分位间距)分别为29.8(25.3 - 39.1)和25.5 U/L(18.1 - 43.3),而健康对照为17.7 U/L(13.7 - 21.2),p分别为0.006和0.02。RA和OA患者滑液中的浓度均低于血清中的浓度。这些发现可能表明MFAP4参与了与慢性关节疾病相关的适应性血管壁重塑。